The interscan variation of CT coronary artery calcification score: analysis of the Calcium Acetate Renagel Comparison (CARE)-2 study
- PMID: 18078907
- DOI: 10.1016/j.acra.2007.08.011
The interscan variation of CT coronary artery calcification score: analysis of the Calcium Acetate Renagel Comparison (CARE)-2 study
Abstract
Rationale and objectives: In the Calcium Acetate Renagel Evaluation (CARE)-2 study, the effects of calcium acetate plus atorvastatin (Lipitor) on the progression of coronary artery calcifications (CACs) are evaluated versus those of Renagel, monitored using dual electron beam tomography (EBT) scans (two scans at study initiation and two at follow up). The aim of this study is to estimate the interscan variation for the Agatston score and for the volume score determined in patients with end-stage renal disease (ESRD) in the CARE-2 study.
Materials and methods: CAC score and volume were measured at study initiation in 463 ESRD subjects (mean age: 59.4 +/- 12.5 years, 48.3% female). All patients underwent dual scanning using an EBT, as first scan of two needed to measure the progression of CAC when treated with sevelamer (Renagel) compared with calcium acetate with or without atorvastatin. All scans in all participants were completed by using an EBT system (GE Imatron, South San Francisco, CA). Interscan variability was defined by the following formula: abs (scan A - scan B) / (0.5 x scan A + 0.5 x scan B) x 100%, where A and B denote the first and second scan, respectively, of the dual scan procedure performed before treatment. We evaluated the reproducibility of the cutpoints commonly used for calcium scores clinically, namely 1-30, 31-100, 101-400, and >400.
Results: The CAC interscan variability was 11.8% using the Agatston score and 10.3% using the volume score. The reproducibility was then assessed using cutpoints 1-30, 31-100, 101-400, and >400. Agatston score variability for the four subgroups was 61.3%, 23%, 16.1%, and 8.2%, respectively (mean variability, 11.8%). Volume score variability was 60.0%, 14.4%, 14.6%, and 7.7%, respectively (mean variability, 10.3%). The correlation coefficient for scan A to scan B goes up significantly with increasing calcium scores and reaches 0.99 for scores greater than 400 (P < .0001).
Conclusion: Interscan variability was sufficiently small for patients with calcium scores greater than 30. Our study thus demonstrates a sufficient reproducibility of the calcium score using EBT. This score allows for accurate serial assessment of these patients and for comparing different therapies.
Similar articles
-
A 1-year randomized trial of calcium acetate versus sevelamer on progression of coronary artery calcification in hemodialysis patients with comparable lipid control: the Calcium Acetate Renagel Evaluation-2 (CARE-2) study.Am J Kidney Dis. 2008 Jun;51(6):952-65. doi: 10.1053/j.ajkd.2008.02.298. Epub 2008 Apr 18. Am J Kidney Dis. 2008. PMID: 18423809 Clinical Trial.
-
Evidence for lower variability of coronary artery calcium mineral mass measurements by multi-detector computed tomography in a community-based cohort--consequences for progression studies.Eur J Radiol. 2006 Mar;57(3):396-402. doi: 10.1016/j.ejrad.2005.12.027. Epub 2006 Jan 24. Eur J Radiol. 2006. PMID: 16434160
-
Comparison of coronary artery calcium scores between electron beam computed tomography and 64-multidetector computed tomographic scanner.J Comput Assist Tomogr. 2009 Mar-Apr;33(2):175-8. doi: 10.1097/RCT.0b013e31817579ee. J Comput Assist Tomogr. 2009. PMID: 19346841
-
Coronary calcium measurements: effect of CT scanner type and calcium measure on rescan reproducibility--MESA study.Radiology. 2005 Aug;236(2):477-84. doi: 10.1148/radiol.2362040513. Epub 2005 Jun 21. Radiology. 2005. PMID: 15972340 Review.
-
The Role of a Coronary Artery Calcium Scan in Type 1 Diabetes.Diabetes Technol Ther. 2016 Sep;18(9):594-603. doi: 10.1089/dia.2016.0110. Epub 2016 Sep 1. Diabetes Technol Ther. 2016. PMID: 27585206 Free PMC article. Review.
Cited by
-
Associations between C-reactive protein, coronary artery calcium, and cardiovascular events: implications for the JUPITER population from MESA, a population-based cohort study.Lancet. 2011 Aug 20;378(9792):684-92. doi: 10.1016/S0140-6736(11)60784-8. Lancet. 2011. PMID: 21856482 Free PMC article.
-
Cross-sectional comparison of coronary artery calcium scores between Caucasian men in the United States and Japanese men in Japan: the multi-ethnic study of atherosclerosis and the Shiga epidemiological study of subclinical atherosclerosis.Am J Epidemiol. 2014 Sep 15;180(6):590-8. doi: 10.1093/aje/kwu169. Epub 2014 Aug 13. Am J Epidemiol. 2014. PMID: 25125689 Free PMC article.
-
Epicardial and intra-thoracic adipose tissue and cardiovascular calcifications in type 1 diabetes (T1D) in epidemiology of diabetes Interventions and Complications (EDIC): A pilot study.Am J Prev Cardiol. 2024 Mar 23;18:100650. doi: 10.1016/j.ajpc.2024.100650. eCollection 2024 Jun. Am J Prev Cardiol. 2024. PMID: 38584607 Free PMC article.
-
Heart disease risk factors in midlife predict subclinical coronary atherosclerosis more than 25 years later in survivors without clinical heart disease: the Rancho Bernardo Study.J Am Geriatr Soc. 2009 Jun;57(6):1041-4. doi: 10.1111/j.1532-5415.2009.02268.x. J Am Geriatr Soc. 2009. PMID: 19507296 Free PMC article.
-
Inhibit progression of coronary artery calcification with vitamin K in hemodialysis patients (the iPACK-HD study): a randomized, placebo-controlled multi-center, pilot trial.Nephrol Dial Transplant. 2023 Feb 28;38(3):746-756. doi: 10.1093/ndt/gfac191. Nephrol Dial Transplant. 2023. PMID: 35641194 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical